These S&P500 stocks are gapping in today's session
By Mill Chart
Last update: Mar 11, 2024
Gap analysis of S&P500 on 2024-03-11: gap up and gap down stocks in today's session.
Gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| EQT | -7.84% | Today, EQT CORP's (NYSE:EQT) stock experienced a 7.84% fall to $34.58 with a 10.81% gap. A press release (EQT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of EQT Corporation Is Fair to Shareholders) was released earlier today. |
| LLY | -4.14% | ELI LILLY & CO's (NYSE:LLY) shares suffered a 4.14% decline to $730.59 during Monday's session, accompanied by a 6.64% gap. Shareholders saw the stock price going 27.44% higher in the past 3 months. |
| BLDR | -4.13% | Today, BUILDERS FIRSTSOURCE INC's (NYSE:BLDR) stock experienced a 4.13% fall to $191.59 with a 8.44% gap. Shareholders saw the stock price going 35.3% higher in the past 3 months. |
| META | -3.8% | META PLATFORMS INC-CLASS A's (NASDAQ:META) shares suffered a 3.8% decline to $486.73 during Monday's session, accompanied by a 9.09% gap. In the last 3 months the share price increased with 52.05%. |
| AMD | -3.52% | Today, ADVANCED MICRO DEVICES's (NASDAQ:AMD) stock experienced a 3.52% fall to $200.1 with a 13.46% gap. In the last month the share price increased with 22.46%. |
| BA | -3.38% | BOEING CO/THE's (NYSE:BA) shares fell 3.38% to $191.78 with a gap of 6.87%. |
| HWM | -3.32% | HOWMET AEROSPACE INC's (NYSE:HWM) shares experienced a 3.32% decline to $65.49 during Monday's session, accompanied by a 6.8% gap. The stock is trading 27.19% higher than 3 months ago. |
| HUBB | -3.26% | HUBBELL INC's (NYSE:HUBB) shares suffered a 3.26% decline to $380.33 during Monday's session, accompanied by a 4.2% gap. The stock is trading 27.57% higher than 3 months ago. |
| LRCX | -3.17% | Unfavorable news for LAM RESEARCH CORP's (NASDAQ:LRCX) stock! It witnessed a 3.17% decline to $926.36 in today's session, along with a 7.55% gap. Shareholders saw the stock price going 36.05% higher in the past 3 months. |
| MU | -3.17% | MICRON TECHNOLOGY INC's (NASDAQ:MU) stock price is declining with 3.17% to a price of $94.53 with a gap of 7.5%. In the last 3 months the stock gained 30.23%. |
For the full top loser list go to our gap down stocks screener.
ELI LILLY & CO
NYSE:LLY (5/10/2024, 4:05:00 PM)
After market: 760 0 (0%)760
-11.55 (-1.5%)
LLY News
11 hours ago - InvestorPlace3 Biotech Stocks to Sell in May Before They Crash & BurnDiscover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.
12 hours ago - Zacks Investment ResearchZacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista NetworksEaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
12 hours ago - BloombergNew Weight-Loss, Diabetes Drugs Reach One in Eight AmericansOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity drugs that includes Ozempic and Zepbound, underscoring how quickly the treatments have gained popularity.
a day ago - InvestorPlace7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.
2 days ago - The Motley FoolThis 1 Simple ETF Could Turn $100 a Month Into $93,200Turn small investments into big returns with this surprisingly simple strategy -- and a hands-off ETF investment for the ages.
3 days ago - AB NewswireActinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
3 days ago - CNBCHealthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supplyEli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.
3 days ago - InvestorPlaceBiotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareInvestors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
3 days ago - CNBCAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceAmgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.
3 days ago - Market News VideoLLY February 2025 Options Begin Trading3 days ago - TheNewswire.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"SAN DIEGO, CA - (NewMediaWire) - May 07, 2024 - Sigyn Therapeutics, Inc. (“Sigyn Therapeutics”, “Sigyn” or the “Company”) (OTCQB: “SIGY”), a development-stage medical technology company, announced today that it has published an article entitled: “Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections.” Please note that the information provided in this publication is for informational purposes only and does not constitute an offer to sell, nor is a solicitation to acquire shares of Sigyn Therapeutics.
3 days ago - NewMediaWireSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
